Jim Cramer Highlights Elanco's "Comeback Story"
Elanco Animal Health Incorporated (NYSE:
I love a good comeback story. Right now, there’s a great one playing out in Elanco Animal Health. That’s a veterinary medicine company spun off by Eli Lilly all the way back in 2018. Stock struggled to gain traction for a long time, but it’s now up 137% over the past 12 months and almost 17% since the start of 2026. Today, Elanco rallied another 6.6% after it reported a very strong quarter, 12% revenue growth driven by strength in both pet health and farm animals, and a 2-cent earnings beat off 11 cent basis. At the same time, management gave a very solid full-year forecast. This is a growth company, people.
Elanco Animal Health Incorporated (NYSE:ELAN) sells products to protect and treat pets and farm animals, including parasiticides, vaccines, therapeutics, and medicated feed additives. During the episode aired on December 17, 2025, a caller inquired about the stock and Cramer replied:
They are doing everything right. I am so impressed with the way they’ve turned that company around. I’m glad you brought it out. That was a real good idea.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Why Is Rocket Lab Stock Falling Friday?
PBOC Moves to Stabilize Yuan, Denmark Announces Early Election, Greens Secure Victory in UK By-Election

Gogo: Q4 Financial Results Overview
